Skip to content
ppharmaranks
Menu

Best treatments for acromegaly

8 products may treat acromegaly, spanning FDA drug classes such as somatostatin analog, ergot derivative. The current highest-rated option is sandostatin. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 8 drugs we list for acromegaly, 5 are available as lower-cost generics, spanning classes such as somatostatin analog, ergot derivative. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for acromegaly — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top-rated picks for acromegaly: 1. Sandostatin · 2. Bromocriptine Mesylate · 3. Bynfezia Pen

Top-rated treatments for acromegaly, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$5View →
260/100$52View →
3Not yet rated$5View →
4Not yet rated$52View →
5Not yet ratedView →
6Not yet rated$52View →
7Not yet ratedView →
8Not yet ratedView →

Full ranking · 8 treatments

Frequently asked

What treats acromegaly?
Our catalog lists 8 products that may treat acromegaly, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is sandostatin.
What is the best-rated treatment for acromegaly?
By our independent recall-safety rating — not an efficacy measure — sandostatin ranks highest among the products we list for acromegaly. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat acromegaly?
Treatments for acromegaly span FDA drug classes including somatostatin analog, ergot derivative. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.